Description
OTHER FUNCTIONS - RADIOPHARMACEUTICALS
Base award description: RADIOPHARMACEUTICALS
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-10-01+$195,000= $195,000
- Mod 12011-10-01+$185,327= $380,327
- Mod 22012-10-26+$185,400= $565,727
- Mod P000032013-10-15+$108,000= $673,727
- Mod P000042013-12-11-$14,634= $659,093
- Mod P000052015-05-01-$14,634= $644,459
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-10-01 | +$195,000 | $195,000 | RADIOPHARMACEUTICALS |
| Mod 1· EXERCISE AN OPTION | 2011-10-01 | +$185,327 | $380,327 | RADIOPHARMACEUTICALS |
| Mod 2· EXERCISE AN OPTION | 2012-10-26 | +$185,400 | $565,727 | OTHER FUNCTIONS - RADIOPHARMACEUTICALS |
| Mod P00003· EXERCISE AN OPTION | 2013-10-15 | +$108,000 | $673,727 | OTHER FUNCTIONS - RADIOPHARMACEUTICALS |
| Mod P00004· CHANGE ORDER | 2013-12-11 | −$14,634 | $659,093 | OTHER FUNCTIONS - RADIOPHARMACEUTICALS |
| Mod P00005· CHANGE ORDER | 2015-05-01 | −$14,634 | $644,459 | OTHER FUNCTIONS - RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RQAKL78AXMT5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0481 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $3,356,110 | FY2026 |
| 36C24426P0225 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $148,383 | FY2026 |
| 36C24226D0037 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24226N0381 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $959,170 | FY2026 |
| 36C24425N0451 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $180,327 | FY2025 |
| 36C24225N0376 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $51,681 | FY2025 |
Other recipients under Q201 from 460-WILMINGTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24414P5000 | CELLERATION, INC. | 460-WILMINGTON | $104,328 | FY2014 |
| VA24412F0013 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 460-WILMINGTON | $47,025 | FY2012 |
| VA24412P0307 | LINDE INC. | 460-WILMINGTON | $12,800 | FY2012 |
| V460C20117 | AGILITI HEALTH INC | 460-WILMINGTON | $31,482 | FY2011 |
| VA244P1850 | MELANIE COLE HOLMAN, AU.D., LIMITED LIABILITY COMPANY | 460-WILMINGTON | $182,105 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA244P1563_3600_-NONE-_-NONE- · retrieved 2026-09-27.